Shantani Proteome Analytics Pvt. Ltd. is a biotechnology company that uses advanced chemical proteomics technology to identify new drug targets and validate drug mechanisms of action. The company offers drug discovery services including drug target identification, protein analysis, and assay development. Shantani is also developing a proprietary chemical proteomics technology to identify the cellular protein targets of small molecules, which can capture target proteins from intact biological systems without limitations on protein class and allows quantifying interactions directly in cells.

1. 38 – Company Profiles
Shantani Proteome Analytics Pvt. Ltd.
Drug Discovery
DELEGATE(S) Chaitanya Saxena
MISSION/BACKGROUND
Shantani Proteome Analytics Pvt. Ltd. (Shantani) is a research based biotechnology
company and leader in the use of Advanced Chemical Proteomics Technology. We are
applying our innovative technologies to identify and validate new drug targets and create
path-forward solutions for life-sciences-based products. We offer applications of our
proprietary technologies as services to drug discovery Organizations. Some of the services
that we routine offer are as follows:
1) Application of its proprietary chemo-proteomics technology for Drug Target
Identification, Validation and MOA Studies
2) Advanced protein biochemistry and proteomics services:
x Proteins and peptide quantification in biological matrices using mass-spectrometry based SRM/MRM methods;
x Protein and peptide characterization (comparability studies) using LC-MS, LC-MS/MS, LC-UV/Vis, LC-FTIR, fluorescence
spectroscopy (steady-state and time resolved).
3) 'Fit for purpose' biochemical assay development allowing seamless integration of the novel assays in the product development cycle.
TECHNOLOGY
Shantani is developing a proprietary advanced chemical proteomics technology to identify the cellular protein targets of small-
molecule drugs. Following features together differentiate our technology from other existing chemical-proteomic technologies in the
world:
1) Target proteins are identified for unmodified small-molecules;
2) Target proteins are captured from intact, physiologically relevant biological systems;
3) Capture of target protein is not limited to 'kinase' or any one class of proteins;
4) Method allows the possibilities of quantifying small-molecule target interactions directly in cell-based systems.
100 NCL Innovation Park, Dr. Homi
Bhabha Road
Pune Maharashtra 411008
India
www.shantani.com
Incorporated: 2010
Ownership: Private